Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sa deok Hong"'
Autor:
Nar Bahadur Katuwal, Min Sil Kang, Mithun Ghosh, Sa Deok Hong, Yeong Gyu Jeong, Seong Min Park, Seul-Gi Kim, Joohyuk Sohn, Tae Hoen Kim, Yong Wha Moon
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-21 (2023)
Abstract Background Breast cancer is the global leading cancer burden in women and the hormone receptor-positive (HR+) subtype is a major part of breast cancer. Though cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors are highly effective therapy f
Externí odkaz:
https://doaj.org/article/d6b66fd44da1438f93bf7bcc8096c727
Publikováno v:
Cancer Research. 83:P2-26
Background: The PI3K inhibition has been an appealing approach for anticancer therapy due to its crucial role in cell growth, proliferation, and survival in various cancers. Emerging data suggest the PI3K pathway is also involved in DNA replication a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::541a919fa58ffd23f5558dfa49bc7566
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-09
https://doi.org/10.1158/1538-7445.sabcs22-p2-26-09
Autor:
Nar Bahadur, Katuwal, Nahee, Park, Kamal, Pandey, Min Sil, Kang, Sa Deok, Hong, Mithun, Ghosh, Seul-Gi, Kim, Young Bin, Cho, Jin, Hur, Seung Ki, Kim, Yong Wha, Moon
Publikováno v:
Anticancer Research. 43:85-95
To evaluate the feasibility of syngeneic mouse models of breast cancer by analyzing the efficacy of immune checkpoint inhibitors (ICIs) and potential predictive biomarkers.To establish the murine triple-negative breast cancer (TNBC) models, JC, 4T1,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::010d1cb97eb631e983308acb4c4f14fd
https://doi.org/10.21873/anticanres.16137
https://doi.org/10.21873/anticanres.16137
Autor:
Yong Moon, Mithun Gosh, Hee-Jung An, Tae Hoen Kim, Sa Deok Hong, Nar Bahadur Katuwal, Minsil Kang
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::321d7445d803536eb8a88fae25258461
https://doi.org/10.1136/jitc-2022-sitc2022.0886
https://doi.org/10.1136/jitc-2022-sitc2022.0886
Autor:
Nar Bahadur Bahadur, Nahee Park, Kamal Pandey, Katuwal Nar Bahadur, Min Sil Kang, Sa Deok Hong, Mithun Ghosh, Seul-Gi Kim, Young Bin Cho, Jin Hur, Seung Ki Kim, Yong Wha Moon
Purpose To evaluate the feasibility of syngeneic mouse models of breast cancer by analyzing the efficacy of immune checkpoint inhibitors (ICIs) and potential predictive biomarkers. Methods Four syngeneic mouse models of triple-negative breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b08ced8b1ff2a4ee72a44d216ee2157
https://doi.org/10.21203/rs.3.rs-1986279/v1
https://doi.org/10.21203/rs.3.rs-1986279/v1
Autor:
Min Sil Kang, Nar Katuwal, Mithun Ghosh, Young kyu Jeong, Sa deok Hong, Sung Min Park, John Kim, Hyunju Cha, Banyoon Cheon, Seul-Gi Kim, Yong Wha Moon
Publikováno v:
Cancer Research. 83:4485-4485
PARP inhibitors have prolonged the survival of various cancer patients with homologous recombination (HR) deficiencies. However, most patients eternally acquire resistance. Many attempts have been made, but there are no clear strategies to overcome r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db9eff371ca22ac85f0115e7fe32d823
https://doi.org/10.1158/1538-7445.am2023-4485
https://doi.org/10.1158/1538-7445.am2023-4485
Autor:
Young Bin Cho, Kamal Pandey, Min Sil Kang, Jin Hur, Nar Bahadur Katuwal, Tae Heon Kim, Mithun Ghosh, Yong Wha Moon, Sa Deok Hong, Hee Jung An, Nahee Park
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 3
International Journal of Molecular Sciences, Vol 22, Iss 1223, p 1223 (2021)
Volume 22
Issue 3
International Journal of Molecular Sciences, Vol 22, Iss 1223, p 1223 (2021)
Epithelial ovarian cancer remains the leading cause of mortality among all gynecologic malignancies owing to recurrence and ultimate development of chemotherapy resistance in the majority of patients. In the chemotherapy-resistant ovarian cancer prec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582799dbcfbe7c40533c8f234cd9b32b